Everest Medicines Announces Close of Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib
SHANGHAI, July 7, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today...
Hong Kong Slam To Close 2026 As PPA Tour Asia Reveals Calendar
PPA Tour Asia's first-ever Slam brings up to US$1.1 million in Pro prize money and 1,500 PPA Ranking points to one of the world's most electric sporting cities. SINGAPORE, Feb. 25, 2026 /PRNewswire/ -- Pickleball is making port. PPA Tour Asia has...